internal hemorrhoids
Conditions
Interventions
experimental group:Disposable gastrointestinal endoscopy
control group:Traditional reusable endoscopy
Sponsors
Shenzhen Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged range from 18 to 75 years, no gender limit; 2. Grade II-III hemorrhoids with internal hemorrhoid-related symptoms; 3. Conservative treatment of grade II-III hemorrhoids with diet and drugs is ineffective; 4. Voluntarily participate in this clinical trial and have signed written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to minimally invasive endoscopic therapy: (1) Grade I-III hemorrhoids accompanied by incarceration, thrombosis, erosion, infection, etc.; (2) Patients with severe systemic diseases cannot tolerate endoscopic therapy; (3) Perianal infection and anal fistula; (4) Active stage of inflammatory bowel disease; (5) Those allergic to sclerosing agents; (6) Coagulation dysfunction or use of anticoagulant drugs; (7) Pregnant patients; 2. Patients who had participated in other clinical trials 1 month before screening; 3. Patients with previous history of anesthesia drug allergy; 4. The researchers think it is not suitable for participants in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference of blood routine and infection index between preoperative and postoperative patients;Qualified rate of clinical feasibility of one-time endoscopic minimally invasive treatment of internal hemorrhoids;Incidence of postoperative infection; | — |
Countries
China
Contacts
Public ContactGong Wei
Outcome results
None listed